Identifying influencing factors of metabolic syndrome in patients with major depressive disorder: A real-world study with Bayesian network modeling

被引:2
作者
Qi, Han [1 ,2 ,3 ]
Liu, Rui [1 ,2 ,3 ]
Dong, Cheng-Cheng [1 ,2 ,3 ]
Zhu, Xue-Quan [1 ,2 ,3 ]
Feng, Yuan [1 ,2 ,3 ]
Wang, Hai-Ning [4 ]
Li, Lei [5 ,7 ,8 ,9 ]
Chen, Fei [6 ]
Wang, Gang [1 ,2 ,3 ]
Yan, Fang [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Anding Hosp, Natl Clin Res Ctr Mental Disorders, Beijing Key Lab Mental Disorders, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Anding Hosp, Natl Ctr Mental Disorders, Beijing, Peoples R China
[3] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100088, Peoples R China
[4] Peking Univ Third Hosp, Dept Endocrinol & Metab Dis, Beijing, Peoples R China
[5] Peking Univ Third Hosp, Dept Cardiol, Beijing, Peoples R China
[6] Peking Univ, Peking Univ Hlth Sci Ctr, Grad Sch, Beijing, Peoples R China
[7] Peking Univ, State Key Lab Vasc Homeostasis & Remodeling, Beijing, Peoples R China
[8] Peking Univ, NHC Key Lab Cardiovasc Mol Biol & Regulatory Pepti, Beijing, Peoples R China
[9] Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China
关键词
Major depressive disorder; Metabolic syndrome; Bayesian network; Real-world data; Influencing factors; MENTAL-DISORDERS; PREVALENCE; ASSOCIATION; HEALTH; RISK;
D O I
10.1016/j.jad.2024.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The bidirectional relationships between metabolic syndrome (MetS) and major depressive disorder (MDD) were discovered, but the influencing factors of the comorbidity were barely investigated. We aimed to fully explore the factors and their associations with MetS in MDD patients. Methods: The data were retrieved from the electronic medical records of a tertiary psychiatric hospital in Beijing from 2016 to 2021. The influencing factors were firstly explored by univariate analysis and multivariate logistic regressions. The propensity score matching was used to reduce the selection bias of participants. Then, the Bayesian networks (BNs) with hill-climbing algorithm and maximum likelihood estimation were preformed to explore the relationships between influencing factors with MetS in MDD patients. Results: Totally, 4126 eligible subjects were included in the data analysis. The proportion rate of MetS was 32.6 % (95 % CI: 31.2 %-34.1 %). The multivariate logistic regression suggested that recurrent depression, uric acid, duration of depression, marriage, education, number of hospitalizations were significantly associated with MetS. In the BNs, number of hospitalizations and uric acid were directly connected with MetS. Recurrent depression and family history psychiatric diseases were indirectly connected with MetS. The conditional probability of MetS in MDD patients with family history of psychiatric diseases, recurrent depression and two or more times of hospitalizations was 37.6 %. Conclusion: Using the BNs, we found that number of hospitalizations, recurrent depression and family history of psychiatric diseases contributed to the probability of MetS, which could help to make health strategies for specific MDD patients.
引用
收藏
页码:308 / 316
页数:9
相关论文
共 50 条
[41]   Identifying factors associated with the hospital readmission rate among patients with major depressive disorder [J].
Sharareh Parami ;
Leili Tapak ;
Jalal Poorolajal ;
Abbas Moghimbeigi ;
Ali Ghaleiha .
BMC Psychiatry, 21
[42]   Identifying factors associated with the hospital readmission rate among patients with major depressive disorder [J].
Parami, Sharareh ;
Tapak, Leili ;
Poorolajal, Jalal ;
Moghimbeigi, Abbas ;
Ghaleiha, Ali .
BMC PSYCHIATRY, 2021, 21 (01)
[43]   Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder [J].
Wang, Dan ;
Li, Zexuan ;
Li, Lingjiang ;
Hao, Wei .
ASIA-PACIFIC PSYCHIATRY, 2014, 6 (02) :152-160
[44]   Impact of high-frequency rTMS combined with pharmacotherapy on the left dorsolateral prefrontal cortex in treating major depressive disorder: A real-world study [J].
Yang, Jun ;
Xie, Guojun ;
Yi, Li ;
Liang, Jiaquan ;
Shao, Zhiyong ;
Li, Qidi ;
Huang, Wei ;
Sun, Jinyan ;
Wu, Kai ;
Xu, Jinbing .
JOURNAL OF AFFECTIVE DISORDERS, 2025, 368 :67-72
[45]   Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study [J].
Wang, Gang ;
Xiao, Le ;
Ren, Hongye ;
Simonsen, Kenneth ;
Ma, Jingdong ;
Xu, Xiangdong ;
Guo, Ping ;
Wang, Zhiren ;
Bai, Ludong ;
Reines, Elin Heldbo ;
Hammer-Helmich, Lene .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 :1939-1950
[46]   Association of paraoxonase-1 activity and major depressive disorder in patients with metabolic syndrome [J].
Hatem Ari ;
Mehmet Kayrak ;
Mehmet Gündüz ;
Fatih Kayhan ;
Zeynettin Kaya ;
Aysel Kiyici ;
Faruk Uguz .
International Journal of Diabetes in Developing Countries, 2015, 35 :258-263
[47]   Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting [J].
Correll, Christoph U. ;
Cutler, Andrew J. ;
Laliberte, Francois ;
Germain, Guillaume ;
Macknight, Sean D. ;
Boudreau, Julien ;
Wade, Sally W. ;
Nabulsi, Nadia ;
Nguyen, Huy-Binh ;
Parikh, Mousam .
ANNALS OF GENERAL PSYCHIATRY, 2025, 24 (01)
[48]   Real-World Treatment Costs and Care Utilization in Patients with Major Depressive Disorder With and Without Psychiatric Comorbidities in Specialist Mental Healthcare [J].
Kan, Kaying ;
Lokkerbol, Joran ;
Jorg, Frederike ;
Visser, Ellen ;
Schoevers, Robert A. ;
Feenstra, Talitha L. .
PHARMACOECONOMICS, 2021, 39 (06) :721-730
[49]   Four modifiable factors that mediate the effect of educational time on major depressive disorder risk: A network Mendelian randomization study [J].
Wan, Bangbei ;
Wu, Yamei ;
Ma, Ning ;
Zhou, Zhi ;
Lu, Weiying .
PLOS ONE, 2023, 18 (07)
[50]   Investigation of the pharmacological treatment patterns of Chinese patients with major depressive disorder under real-world settings using multi-channel sequence analysis [J].
Wu, Tao ;
Dong, Sijia ;
Yang, Lu ;
Qiu, Hong ;
Qiu, Hong ;
Mellor, David ;
Chen, Jun ;
Xu, Yifeng .
FRONTIERS IN PSYCHIATRY, 2023, 14